William Sikov
9PUBLICATIONS
58CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 22, 2022
Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis.Kara K Landry, Jessica L Lyon, Kitty E Victoria
|Jan 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley
|Nov 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.Otto Metzger-Filho, Katharine Collier, Sarah Asad
|Jun 07, 2021
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga
|Jun 04, 2021
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.M L Lopresti, J J Bian, B J Sakr
Pageof 2
Frequent Collaborators
3 joint publications
William F Symmans
2 joint publications
Eve T Rodler
2 joint publications
Lynne I Wagner
2 joint publications
Erica L Mayer
2 joint publications
Ingrid A Mayer
2 joint publications
Ben H Park
2 joint publications
Amye J Tevaarwerk
2 joint publications
Sofia F Garcia
2 joint publications
Karen L Smith
2 joint publications
Bernard Tawfik